封面
市场调查报告书
商品编码
1777870

全球血液和血液成分市场

Blood and Blood Components

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 370 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2030年,全球血液和血液成分市场规模将达到148亿美元

全球血液及血液成分市场规模预计在2024年为130亿美元,预计到2030年将达到148亿美元,2024年至2030年的复合年增长率为2.2%。血液成分是本报告分析的细分市场之一,预计其复合年增长率为2.8%,到分析期结束时规模将达到86亿美元。全血细分市场在分析期间的复合年增长率预计为1.5%。

美国市场规模估计为 35 亿美元,中国市场预期复合年增长率为 4.4%

预计2024年,美国血液及血液成分市场规模将达35亿美元。作为世界第二大经济体的中国,预计2030年市场规模将达到28亿美元,在2024-2030年的分析期间内,复合年增长率为4.4%。其他值得关注的区域市场包括日本和加拿大,预计在分析期间内,这两个市场的复合年增长率分别为0.7%和1.7%。在欧洲,预计德国市场的复合年增长率为1.2%。

全球血液和血液成分市场—主要趋势和驱动因素摘要

为什么整个医疗保健系统对血液和血液成分的需求不断增加?

血液和血液成分在现代医学中发挥着至关重要的作用,在外科手术、创伤护理、癌症治疗、慢性病管理等领域发挥着挽救生命的治疗作用。由于贫血、血友病、白血病和其他血液疾病的发生率不断上升,全球对包括红血球 (RBC)、血小板、血浆和凝血因子在内的血液製品的需求正在增长。此外,器官移植、复杂手术和积极化疗等医疗程序的进步进一步增加了对稳定高效血液供应的需求。

输血仍然是急诊护理的基本组成部分,尤其是在应对意外事故、战场伤势和产妇分娩出血时。此外,人口老化加剧了血液相关疾病的易感性,这也加剧了人们对血液成分的依赖。儘管需求不断增长,但挑战依然存在,包括血液短缺、捐赠者数量不足以及对输血传染感染疾病(TTI) 的担忧。为了解决这些问题,医疗机构、血库和生技公司正在探索创新解决方案,包括合成血液替代品、病原体灭活技术和先进的血液储存技术。

科技进步如何改善血液的采集、处理和储存?

血液处理和输血医学领域的技术创新显着提高了血液和血液成分的安全性、效率和可用性。其中最具影响力的进展之一是病原体去除技术 (PRT) 的开发,该技术可以去除血液製品中的病毒、细菌和寄生虫,从而降低输血传播感染疾病的风险。这些处理方法,例如紫外线病原体灭活和溶剂-清洁剂等离子体处理,正在提高全球输血的安全性。

可以选择性地采集血浆、血小板和红血球等特定血液成分,而将剩余血液送回捐赠者体内。单采血液成分不仅提高了捐赠者的保留率,而且还透过减少全血捐血的需求提高了血液采集效率。此外,冷冻保存和长期血液储存技术的进步解决了供应链挑战并确保了血液成分的长期有效性,特别是在偏远和灾害多发地区。合成血液的持续发展,包括基于血红蛋白的氧载体 (HBOC) 和基于全氟碳 (PFC) 的血液替代,为紧急输血和军事应用带来了希望,有可能减少对捐献血液供应的依赖。

哪些市场趋势推动了血液和血液成分产业的发展?

由于疾病盛行率上升、外科手术增多、医疗基础设施改善等因素,全球血液及血液成分市场正在扩张。影响该行业的最显着趋势之一是对血浆衍生疗法的日益重视。血浆分馏已成为关键的投资领域,因为血浆衍生产品对于治疗免疫力缺乏、血友病和神经系统疾病至关重要。对免疫球蛋白、白蛋白和凝血因子的需求不断增长,促使生物製药公司扩大其血浆采集网路并投资大型分离设施。

影响市场的另一个主要趋势是自愿和无偿捐血政策的转变。许多国家正在实施倡议,透过提高意识的宣传活动、奖励和数位参与策略来改善捐血者的招募和保留。此外,区块链和数位追踪系统在血液供应链中的整合正在提高透明度、减少浪费并改善血库的可追溯性。个人化医疗和再生医学的扩展也推动了人们对自体输血的兴趣,自体输血是指在手术或癌症治疗期间采集并回输患者自身的血液。随着医疗保健系统优先考虑效率和安全性,数位化血液管理解决方案和先进捐血者筛检技术的采用有望进一步简化血液的收集和分配。

影响血液和血液成分市场未来发展的关键成长动力有哪些?

血液及血液成分市场的成长受到多种关键因素的推动,包括慢性病负担的加重、输血医学的进步以及对血液安全和供应链优化的投资不断增加。其中一个主要成长要素是外科手术和创伤病例的增加,这些病例需要可靠的血液供应。随着全球范围内择期手术和急诊手术数量的增加,医院和医疗保健机构正在投资血库和输血服务,以确保在关键手术期间有充足的血液供应。

影响市场的另一个关键驱动因素是对血浆衍生疗法不断增长的需求。生物製药产业专注于免疫力缺乏治疗、血友病治疗和新型血浆疗法,这推动了血浆收集工作的增加和重组疗法的研究。此外,采用先进的捐赠者筛检技术,例如核酸检测 (NAT) 和人工智慧风险评估模型,正在提高血液安全性并降低输血相关併发症的发生率。随着政府和医疗保健组织加强对捐血、处理和输血实践的法律规范,市场有望继续扩张。随着合成血液替代品、病原体灭活策略和数位健康整合的不断创新,血液和血液成分产业的未来将由增强的安全性、效率和可及性来定义,从而确保全球患者获得更好的治疗效果。

部分

产品类型(血液成分、全血)、用途(贫血、创伤/手术、癌症治疗、出血性疾病、其他)、最终用途(医院、门诊手术中心、其他)

受访公司范例

  • American Association of Blood Banks(AABB)
  • American Red Cross
  • Australian Red Cross
  • Baxter International Inc.
  • Beckman Coulter, Inc.
  • Bio Products Laboratory(BPL)
  • bioMerieux SA
  • Cerus Corporation
  • CSL Limited
  • European Blood Alliance
  • Fresenius SE & Co. KGaA
  • Grifols, SA
  • Haemonetics Corporation
  • Hualan Biological Engineering Inc.
  • Immucor, Inc.
  • Indian Red Cross Society
  • Kedrion Biopharma
  • Maco Pharma International GmbH
  • Mitsubishi Tanabe Pharma Corporation
  • Octapharma AG
  • South African National Blood Service
  • Takeda Pharmaceutical Company Limited
  • Teleflex Incorporated
  • Terumo Corporation

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询,而是建立了一个从世界各地的专家收集的内容库,其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地以及进出口情况(成品和原始OEM)预测其竞争地位的变化。这种复杂多变的市场动态预计将以多种方式影响竞争对手,包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP29642

Global Blood and Blood Components Market to Reach US$14.8 Billion by 2030

The global market for Blood and Blood Components estimated at US$13.0 Billion in the year 2024, is expected to reach US$14.8 Billion by 2030, growing at a CAGR of 2.2% over the analysis period 2024-2030. Blood Components, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$8.6 Billion by the end of the analysis period. Growth in the Whole Blood Type segment is estimated at 1.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.5 Billion While China is Forecast to Grow at 4.4% CAGR

The Blood and Blood Components market in the U.S. is estimated at US$3.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.8 Billion by the year 2030 trailing a CAGR of 4.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.7% and 1.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.2% CAGR.

Global Blood and Blood Components Market - Key Trends & Drivers Summarized

Why Is the Demand for Blood and Blood Components Increasing Across Healthcare Systems?

Blood and blood components play a critical role in modern medicine, serving as life-saving therapeutic products in surgeries, trauma care, cancer treatments, and chronic disease management. With the increasing prevalence of conditions such as anemia, hemophilia, leukemia, and other hematologic disorders, the global demand for blood products-including red blood cells (RBCs), platelets, plasma, and clotting factors-continues to rise. Additionally, advancements in medical procedures, including organ transplants, complex surgeries, and aggressive chemotherapy treatments, have further elevated the need for a stable and efficient blood supply.

Blood transfusion remains a fundamental component of emergency medicine, particularly in response to accidents, battlefield injuries, and maternal hemorrhage during childbirth. Moreover, the growing geriatric population, which is more susceptible to blood-related disorders, has contributed to an increasing reliance on blood components. Despite the rising demand, challenges such as blood shortages, donor recruitment, and concerns over transfusion-transmitted infections (TTIs) persist. To address these issues, healthcare organizations, blood banks, and biotech firms are exploring innovative solutions, including artificial blood substitutes, pathogen reduction technologies, and advanced blood storage techniques.

How Are Technological Advancements Enhancing Blood Collection, Processing, and Storage?

Innovations in blood processing and transfusion medicine are significantly improving the safety, efficiency, and availability of blood and blood components. One of the most impactful advancements is the development of pathogen reduction technologies (PRTs), which help eliminate viruses, bacteria, and parasites from blood products, reducing the risk of transfusion-transmitted infections. These technologies, including UV light-based pathogen inactivation and solvent-detergent plasma treatment, are enhancing the safety profile of blood transfusions worldwide.

Another breakthrough in the blood industry is the introduction of automated apheresis systems, which allow for the selective collection of specific blood components such as plasma, platelets, or red blood cells while returning the remaining blood to the donor. Apheresis not only improves donor retention but also increases the efficiency of blood collection by reducing the need for whole blood donations. Additionally, advancements in cryopreservation and extended blood storage techniques are addressing supply chain challenges, ensuring that blood components remain viable for longer durations, especially in remote or disaster-stricken regions. The ongoing development of synthetic blood substitutes, including hemoglobin-based oxygen carriers (HBOCs) and perfluorocarbon-based (PFC) blood substitutes, holds promise for emergency transfusions and military applications, potentially reducing dependency on donor blood supplies.

Which Market Trends Are Driving Growth in the Blood and Blood Components Industry?

The global blood and blood components market is expanding due to a combination of rising disease prevalence, increasing surgical procedures, and improvements in healthcare infrastructure. One of the most prominent trends shaping the industry is the growing emphasis on plasma-derived therapies. Plasma fractionation has become a key area of investment, as plasma-derived products are essential in treating immunodeficiency disorders, hemophilia, and neurological conditions. With rising demand for immunoglobulins, albumin, and clotting factors, biopharmaceutical companies are expanding plasma collection networks and investing in large-scale fractionation facilities.

Another key trend influencing the market is the shift toward voluntary and non-remunerated blood donation policies. Many countries are implementing initiatives to improve donor recruitment and retention through awareness campaigns, incentives, and digital engagement strategies. Additionally, the integration of blockchain and digital tracking systems in blood supply chains is enhancing transparency, reducing wastage, and improving traceability in blood banking. The expansion of personalized medicine and regenerative therapies is also driving interest in autologous blood transfusions, where a patient’s own blood is collected and reinfused during surgeries or cancer treatments. As healthcare systems prioritize efficiency and safety, the adoption of digital blood management solutions and advanced donor screening techniques is expected to further streamline blood collection and distribution.

What Are the Key Growth Drivers Shaping the Future of the Blood and Blood Components Market?

The growth in the blood and blood components market is driven by several critical factors, including the increasing burden of chronic diseases, advancements in transfusion medicine, and rising investments in blood safety and supply chain optimization. One of the primary growth drivers is the expanding number of surgical procedures and trauma cases, necessitating a reliable blood supply. With an increasing number of elective and emergency surgeries being performed worldwide, hospitals and healthcare providers are investing in blood banking and transfusion services to ensure availability during critical interventions.

Another crucial driver shaping the market is the growing demand for plasma-derived therapeutics. The biopharmaceutical industry’s focus on immunodeficiency treatments, hemophilia care, and novel plasma-based therapies has led to increased plasma collection efforts and research into recombinant alternatives. Additionally, the adoption of advanced donor screening technologies, including nucleic acid testing (NAT) and AI-driven risk assessment models, is improving blood safety and reducing the incidence of transfusion-related complications. As governments and healthcare organizations strengthen regulatory frameworks for blood donation, processing, and transfusion practices, the market is poised for continued expansion. With ongoing innovations in synthetic blood substitutes, pathogen reduction strategies, and digital health integration, the future of the blood and blood components industry will be defined by enhanced safety, efficiency, and accessibility, ensuring better patient outcomes worldwide.

SCOPE OF STUDY:

The report analyzes the Blood and Blood Components market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Blood Components, Whole Blood Type); Application (Anemia Application, Trauma and Surgery Application, Cancer Treatment Application, Bleeding Disorders Application, Other Applications); End-Use (Hospitals End-Use, Ambulatory Surgical Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • American Association of Blood Banks (AABB)
  • American Red Cross
  • Australian Red Cross
  • Baxter International Inc.
  • Beckman Coulter, Inc.
  • Bio Products Laboratory (BPL)
  • bioMerieux SA
  • Cerus Corporation
  • CSL Limited
  • European Blood Alliance
  • Fresenius SE & Co. KGaA
  • Grifols, S.A.
  • Haemonetics Corporation
  • Hualan Biological Engineering Inc.
  • Immucor, Inc.
  • Indian Red Cross Society
  • Kedrion Biopharma
  • Maco Pharma International GmbH
  • Mitsubishi Tanabe Pharma Corporation
  • Octapharma AG
  • South African National Blood Service
  • Takeda Pharmaceutical Company Limited
  • Teleflex Incorporated
  • Terumo Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Blood and Blood Components - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Demand for Transfusion Therapies Throws the Spotlight on Blood and Blood Component Supply Chains
    • Growth in Surgical Procedures and Trauma Cases Drives Steady Demand for Red Blood Cells and Whole Blood Products
    • Expansion of Hematological and Oncology Treatments Strengthens the Business Case for Platelet and Plasma Component Utilization
    • Aging Population and Associated Chronic Diseases Fuel Long-Term Demand for Blood-Based Therapeutics
    • Increasing Use of Plasma-Derived Medicinal Products (PDMPs) Expands Addressable Market Opportunity for Plasma Collection and Processing
    • Technological Advancements in Apheresis and Component Separation Enhance Efficiency and Product Quality
    • Growing Awareness and Adoption of Patient Blood Management (PBM) Programs Spur Rational Use of Blood Components
    • Development of Recombinant and Synthetic Alternatives Creates a Balancing Dynamic in Blood Component Markets
    • Rise in Voluntary Blood Donation Campaigns Strengthens Public Health Infrastructure in Emerging Economies
    • Increasing Prevalence of Rare Blood Disorders and Autoimmune Conditions Generates Demand for Specialized Component Therapies
    • Integration of Pathogen Reduction Technologies (PRT) Enhances Safety and Shelf-Life of Blood Components
    • Growth of Cell Therapy and Regenerative Medicine Markets Opens New Avenues for Blood-Derived Cellular Components
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Blood and Blood Components Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Blood and Blood Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Blood and Blood Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Blood and Blood Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Blood Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Blood Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Blood Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Whole Blood Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Whole Blood Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Whole Blood Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Ambulatory Surgical Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Ambulatory Surgical Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Anemia Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Anemia Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Anemia Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Trauma & Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Trauma & Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Trauma & Surgery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Cancer Treatment Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Cancer Treatment Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Cancer Treatment Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Bleeding Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Bleeding Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Bleeding Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Blood and Blood Components by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Blood and Blood Components by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Blood and Blood Components by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Blood and Blood Components by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Blood and Blood Components by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Blood and Blood Components by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Blood and Blood Components by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Blood and Blood Components by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Blood and Blood Components by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Blood and Blood Components by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Blood and Blood Components by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Blood and Blood Components by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Blood and Blood Components Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Blood and Blood Components by Product Type - Blood Components and Whole Blood Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Blood and Blood Components by Product Type - Percentage Breakdown of Value Sales for Blood Components and Whole Blood Type for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Blood and Blood Components by End-Use - Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Blood and Blood Components by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Ambulatory Surgical Centers End-Use for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Blood and Blood Components by Application - Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Blood and Blood Components by Application - Percentage Breakdown of Value Sales for Anemia Application, Trauma & Surgery Application, Cancer Treatment Application, Bleeding Disorders Application and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION